Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pherecydes Pharma SA

www.pherecydes-pharma.com

Latest From Pherecydes Pharma SA

Venture Funding Deals: BioNTech's Big Money Leads January Financings

BioNTech's $270m Series A round was the biggest start-up financing in January, but sizeable rounds also were raised by Centrexion ($67m), Eureka ($60m) and Pandion ($58m).

StartUps and SMEs Financing

Finance Watch: Pandion's $55m Series A Funds Localized Bispecifics For Autoimmune Diseases

Pandion, led by former Pfizer SVP Anthony Coyle, launched in 2017 to exploit immuno-oncology advances for autoimmune and inflammatory diseases; the firm's Series A follows a record-breaking year for biopharma venture capital. In public company financings, AveXis and others seek cash to fuel R&D.

Financing StartUps and SMEs

Pherecydes Pharma SA

Scientists have long realized that certain viruses can destroy bacteria. Classified as bacteriophages, these viruses attach to specific receptors on the surface of bacteria and inject their own genetic material. Some so-called lytic phages kill their hosts right away and their progeny replicate as soon as the bacteria are lysed, or ruptured. Pherecydes Pharma SA, a start-up based in Romainville, France, is working to identify and modify large numbers of lytic phages, with the goal of creating therapies effective against antibiotic-resistant nosocomial infections.

BioPharmaceutical

Start-Up Previews

This Month's Profile Group: Diabetes Drug Development, Seeing Light In The Dark Ages?, features profiles of Ember Therapeutics, Metabolic Solutions, NovaTarg and Thermalin Diabetes. Plus these Start-Ups Across Health Care: HepatoChem, Nimbic Systems, Pherecydes Pharma and Vascular Access Technologies.

See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Pherecydes Pharma SA
  • Senior Management
  • Guy-Charles Fanneau de La Horie, CEO
    Patrick Champion-Arnaud, CMO
    Cindy Fevre, CMO
  • Contact Info
  • Pherecydes Pharma SA
    Phone: (0)1 48 40 65 35
    102 avenue Gaston Roussel
    Biocitech
    Romainville, 93230
    France
UsernamePublicRestriction

Register